Prevention of delayed emesis caused by chemotherapy.
Harmon
D
D
O'Brien
B
B
D000932:Antiemetics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D015986:Confounding Factors, Epidemiologic; D003907:Dexamethasone / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006207:Half-Life; D006801:Humans; D008597:Menstrual Cycle; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017294:Ondansetron / Q000627:therapeutic use*; D010919:Placebos; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D010919:Placebos; D017294:Ondansetron; D003907:Dexamethasone